Cargando…
Toll like receptors TLR1/2, TLR6 and MUC5B as binding interaction partners with cytostatic proline rich polypeptide 1 in human chondrosarcoma
Metastatic chondrosarcoma is a bone malignancy not responsive to conventional therapies; new approaches and therapies are urgently needed. We have previously reported that mTORC1 inhibitor, antitumorigenic cytostatic proline rich polypeptide 1 (PRP-1), galarmin caused a significant upregulation of t...
Autores principales: | Galoian, Karina, Abrahamyan, Silva, Chailyan, Gor, Qureshi, Amir, Patel, Parthik, Metser, Gil, Moran, Alexandra, Sahakyan, Inesa, Tumasyan, Narine, Lee, Albert, Davtyan, Tigran, Chailyan, Samvel, Galoyan, Armen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743405/ https://www.ncbi.nlm.nih.gov/pubmed/29138803 http://dx.doi.org/10.3892/ijo.2017.4199 |
Ejemplares similares
-
Morpho-functional study of the hypothalamic proline-rich polypeptide apoptotic activity against mouse Ehrlich ascites carcinoma
por: Abrahamyan, S., et al.
Publicado: (2020) -
Cancer stem cells as a therapeutic target in 3D tumor models of human chondrosarcoma: An encouraging future for proline rich polypeptide-1
por: Granger, Caroline J., et al.
Publicado: (2020) -
Association of GILZ with MUC2, TLR2, and TLR4 in Inflammatory Bowel Disease
por: Cari, Luigi, et al.
Publicado: (2023) -
Epigenetic regulation of embryonic stem cell marker miR302C in human chondrosarcoma as determinant of antiproliferative activity of proline-rich polypeptide 1
por: GALOIAN, KARINA, et al.
Publicado: (2015) -
Immunogenicity of MultiTEP-Platform-Based Recombinant Protein Vaccine, PV-1950R, Targeting Three B-Cell Antigenic Determinants of Pathological α-Synuclein
por: Zagorski, Karen, et al.
Publicado: (2022)